Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

296 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis

NCT04544449

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Alabama Neurology Associates Homewood, Alabama, United States
  • Sutter East Bay Medical Foundation Berkeley, California, United States
  • Fullerton Neurology and Headache Center Fullerton, California, United States
  • Palo Alto Medical Foundation Research Center Sunnyvale, California, United States
View all 190 locations
View Trial Details
Active, not recruiting

Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS

NCT03535298

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • University of Colorado-Anschutz Medical Campus Aurora, Colorado, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada, United States
View all 30 locations
View Trial Details
Active, not recruiting

Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis

NCT04688788

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +13 more
Locations
  • Danish Multiple Sclerosis Center, Rigshospitalet Glostrup Municipality, Copenhagen, Denmark
  • Department of Neurology, Aalborg University Hospital Aalborg, Denmark
  • Department of Neurology, Aarhus University Hospital Aarhus, Denmark
  • Department of Neurology, Hospital of South West Jutland, Esbjerg Esbjerg, Denmark
View Trial Details
Active, not recruiting

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

NCT06372145

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • The University of Alabama at Birmingham- Site Number : 8400013 Birmingham, Alabama, United States
  • ~North Central Neurology Associates, PC- Site Number : 8400009 Cullman, Alabama, United States
  • Center for Neurology and Spine- Site Number : 8400089 Phoenix, Arizona, United States
  • Collaborative Neuroscience Research- Site Number : 8400045 Los Alamitos, California, United States
View all 352 locations
View Trial Details
Active, not recruiting

A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis

NCT03523858

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • MS Center of California Laguna Hills, California, United States
  • SC3 Research Group, Inc Pasadena, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of South Florida Tampa, Florida, United States
View all 120 locations
View Trial Details
Active, not recruiting

A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)

NCT05123703

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • UC San Diego La Jolla, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins Medicine Baltimore, Maryland, United States
View all 71 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participants With Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis

NCT07483450

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +11 more
Locations
  • The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • Peking Union Medical College Hospital Beijing, China
  • Peking University First Hospital Beijing, China
  • Beijing Hospital of Ministry of Health Beijing, China
View all 17 locations
View Trial Details
Active, not recruiting

A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients

NCT06292923

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Yale North Haven, Connecticut, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • University of Massachusetts Worcester, Massachusetts, United States
View Trial Details

Related conditions